Compare3F TherapeuticsvsNeoChord
Customers evaluate the quality of3F Therapeutics's products using the following success metrics.
Overview
3F Therapeutics is 25 yrs old and is based in United States.
3F Therapeutics developes devices to treat heart valve disorders.
NeoChord is 16 yrs old and is based in United States.
NeoChord is a medical technology company engaged in the advancement of beating heart mitral valve repair in patients suffering from mitral valve regurgitation. The company's flagship product, the NeoChord Artificial Chordae Delivery System, is a beating heart procedure, echo-guided treatment for patients with mitral valve regurgitation and is proven to resolve and restore normal mitral valve function. The company was founded in 2007 and is based in Minneapolis, Minnesota.
Demo Video
領導
Rodolfo C Quijano(Chief Technology Officer)
John Seaberg(Founder)
Investors
ATS Medical,Domain Associates
Treo Venture,Baird Capital Partners
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because3F Therapeuticshas not claimed their profile.
Work for3F Therapeutics? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for3F Therapeutics?
Claim your profile now.
Information not available becauseNeoChordhas not claimed their profile.
Work forNeoChord? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work forNeoChord?
Claim your profile now.
Expert Collections
Medical Devices
8,633 items
Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.
Health IT
7,901 items